Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95


IRF7: activation, regulation, modification and function.

Ning S, Pagano JS, Barber GN.

Genes Immun. 2011 Sep;12(6):399-414. doi: 10.1038/gene.2011.21. Epub 2011 Apr 14. Review.


The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7.

Ning S, Pagano JS.

J Virol. 2010 Jun;84(12):6130-8. doi: 10.1128/JVI.00364-10. Epub 2010 Apr 14.


Epstein-Barr virus latent membrane protein 1 regulates the function of interferon regulatory factor 7 by inducing its sumoylation.

Bentz GL, Shackelford J, Pagano JS.

J Virol. 2012 Nov;86(22):12251-61. doi: 10.1128/JVI.01407-12. Epub 2012 Sep 5.


The Linear Ubiquitin Assembly Complex Modulates Latent Membrane Protein 1 Activation of NF-κB and Interferon Regulatory Factor 7.

Wang L, Wang Y, Zhao J, Ren J, Hall KH, Moorman JP, Yao ZQ, Ning S.

J Virol. 2017 Jan 31;91(4). pii: e01138-16. doi: 10.1128/JVI.01138-16. Print 2017 Feb 15.


Interferon regulatory factor 7 is involved in the growth of Epstein-Barr virus-transformed human B lymphocytes.

Xu D, Zhang Y, Zhao L, Cao M, Lingel A, Zhang L.

Virus Res. 2015 Jan 2;195:112-8. doi: 10.1016/j.virusres.2014.09.005. Epub 2014 Oct 7.


Interferon regulatory factor 7 is activated by a viral oncoprotein through RIP-dependent ubiquitination.

Huye LE, Ning S, Kelliher M, Pagano JS.

Mol Cell Biol. 2007 Apr;27(8):2910-8. Epub 2007 Feb 12.


Ataxia telangiectasia mutated kinase mediates NF-κB serine 276 phosphorylation and interferon expression via the IRF7-RIG-I amplification loop in paramyxovirus infection.

Fang L, Choudhary S, Tian B, Boldogh I, Yang C, Ivanciuc T, Ma Y, Garofalo RP, Brasier AR.

J Virol. 2015 Mar;89(5):2628-42. doi: 10.1128/JVI.02458-14. Epub 2014 Dec 17.


IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3.

Song YJ, Izumi KM, Shinners NP, Gewurz BE, Kieff E.

Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18448-53. doi: 10.1073/pnas.0809933105. Epub 2008 Nov 18.


Epstein-Barr virus interferes with the amplification of IFNalpha secretion by activating suppressor of cytokine signaling 3 in primary human monocytes.

Michaud F, Coulombe F, Gaudreault E, Paquet-Bouchard C, Rola-Pleszczynski M, Gosselin J.

PLoS One. 2010 Jul 30;5(7):e11908. doi: 10.1371/journal.pone.0011908.


Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.

Tao Y, Shi Y, Jia J, Jiang Y, Yang L, Cao Y.

Expert Rev Mol Med. 2015 Aug 18;17:e15. doi: 10.1017/erm.2015.13. Review.


TRAF6 and the three C-terminal lysine sites on IRF7 are required for its ubiquitination-mediated activation by the tumor necrosis factor receptor family member latent membrane protein 1.

Ning S, Campos AD, Darnay BG, Bentz GL, Pagano JS.

Mol Cell Biol. 2008 Oct;28(20):6536-46. doi: 10.1128/MCB.00785-08. Epub 2008 Aug 18.


Epstein-Barr virus LF2: an antagonist to type I interferon.

Wu L, Fossum E, Joo CH, Inn KS, Shin YC, Johannsen E, Hutt-Fletcher LM, Hass J, Jung JU.

J Virol. 2009 Jan;83(2):1140-6. doi: 10.1128/JVI.00602-08. Epub 2008 Nov 5.


Regulation of the transcriptional activity of the IRF7 promoter by a pathway independent of interferon signaling.

Ning S, Huye LE, Pagano JS.

J Biol Chem. 2005 Apr 1;280(13):12262-70. Epub 2005 Jan 21.


Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression.

Kubota T, Matsuoka M, Chang TH, Tailor P, Sasaki T, Tashiro M, Kato A, Ozato K.

J Biol Chem. 2008 Sep 12;283(37):25660-70. doi: 10.1074/jbc.M804479200. Epub 2008 Jul 17.


Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha.

Wakisaka N, Kondo S, Yoshizaki T, Murono S, Furukawa M, Pagano JS.

Mol Cell Biol. 2004 Jun;24(12):5223-34.

Supplemental Content

Support Center